The role of skeletal muscle in the pathophysiology of knee OA is poorly understood. To date, the majority of literature has focused on the association of muscle strength with OA symptoms, disease onset and progression. However, deficits or improvements in skeletal muscle strength do not fully explain the mechanisms behind outcome measures in knee OA, such as pain, function and structural disease. This review aims to summarize components of skeletal muscle, providing a holistic view of skeletal muscle mechanisms that includes muscle function, quality and composition and their interactions. Similarly, the role of skeletal muscle in the management of knee OA will be discussed.
Introduction
Skeletal muscle structure and function have been implicated in both knee OA disease development and progression [1, 2] . Specifically, knee extensor muscle weakness has been recognized as a risk factor for the development and progression of knee OA. Strategies to improve skeletal muscle health are increasingly recognized as important in improving symptomatic and functional outcomes in knee OA. Lower limb muscle strengthening exercises are recommended by clinical practice guidelines as a core component of knee OA management [35] . However, the mechanisms underpinning the influence of skeletal muscle in OA pathophysiology are poorly understood. An in-depth understanding of mechanisms behind the role of skeletal muscle health in knee OA can help improve current muscle rehabilitation strategies to prevent disease onset and progression. This narrative review aims to discuss the role of skeletal muscle, highlighting possible pathophysiological mechanisms in OA disease at the anatomical, physiological and molecular levels and discusses recent research in this field.
Three broad categories of skeletal muscle will be addressed as represented diagrammatically in Figure  1 : skeletal muscle biochemical and molecular interactions, skeletal muscle composition and skeletal muscle function. Discussions on biochemical and molecular interactions of skeletal muscle will include biochemical communication of skeletal muscle with surrounding structures and theories of regulation of inflammatory pathways implicated in OA pathogenesis at a genetic level. Discussions on skeletal muscle quality and composition will include literature discussing the implications of the proportion of muscle vs fatty tissue infiltration within skeletal muscle and skeletal muscle composition, which is defined by fibre type, on OA pathophysiology. Under skeletal muscle function, the role of strength and muscle activation patterns in knee OA will be discussed. Although the mechanisms underpinning the betterment seen in OA disease with improved skeletal muscle strength and activation are currently unknown, this review will hopefully theorize relationships linking skeletal muscle composition, biochemical and molecular interactions with muscle function and provide direction for future research. The best evidence available on the role of skeletal muscle in knee OA will be summarized from systematic reviews with meta-analysis and longitudinal studies where possible, and data from cross-sectional studies will be reviewed when the former are not available. The review concludes with a discussion on the role of skeletal muscle in the management of knee OA through exercise.
Role of skeletal muscle in the pathophysiology of knee OA
Skeletal muscle biochemical and molecular interactions
Skeletal muscle is known to produce myokines, consisting of cytokines, peptides and growth factors, which are thought to be regulated by muscle contraction and have effects on metabolism [6] . Besides myokines that are released directly by contracting skeletal muscle, some cytokines may be released by other cell types, such as inflammatory T cells and macrophages, which reside in blood vessels in skeletal muscle [7] . Crosstalk' between skeletal muscle and structures around the joint is of interest, because although increased knee extensor strength is associated with improved symptoms [811] , the underlying mechanisms are unclear [12] . It may be that skeletal muscle crosstalk with its surrounding structures provide a missing link to improvements seen with an increase in muscle strength. It is suggested that myokines (released with muscle contraction during function) interact with structures such as synovial tissue, fat, cartilage and bone at a molecular level, in a paracrine mechanism, and also have autocrine and endocrine functions [1315] . Two plausible mechanistic pathways by which skeletal muscles communicate with surrounding joint structures have been theorized, including anti-inflammatory and pro-chondrogenic mechanisms, which are discussed below.
Anti-inflammatory
Inflammatory cytokines such as IL-1b and TNF-a are known to lead to the destruction of the extracellular matrix (ECM) of the cartilage locally in the OA joint [16] . IL-1b and TNF-a are also thought to contribute to activation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) pathway signalling in both synovial cells and chondrocytes, both commonly implicated in the pathogenesis of OA [16] . Interestingly, chondrocytes that were co-cultured with muscle cells or in a muscle cellconditioned medium resisted inflammatory IL-1b and TNF-a-induced cartilage damage [17] . This was postulated to occur through inhibition of expression of components in the pro-inflammatory cytokine signalling pathways [17] . Research in humans in vivo examining the relationship between myokines and their effect on inflammatory pathways in OA pathogenesis are promising but limited at present.
In a cross-sectional human study, a negative correlation was found between serum and synovial fluid irisin levels, a myokine and knee OA radiographic severity [18] . In contrast, plasma levels of brain-derived neurotrophic factor (BDNF), another myokine, was found to be higher in OA patients compared with healthy controls in another crosssectional study [19] . The authors also reported that in OA patients, SF BDNF levels were 6-fold lower than plasma levels and that plasma BDNF levels were significantly correlated with pain levels [19] . BDNF levels have been associated with TNF-a levels in other joint diseases [20, 21] and it is postulated that plasma BDNF levels are associated with pain in knee OA [19] . It would be insightful if these initial studies were followed up by further human studies in knee OA to improve our understanding of the relationship between myokines and OA pathogenesis.
Indirect support of the role of muscle in the regulation of inflammatory pathways has been reported at a genetic level [22] . Human bone marrowderived mesenchymal The role of skeletal muscle in the pathophysiology stem cells cultured in muscle cellconditioned medium was found to strongly inhibit pro-inflammatory cytokine gene expression compared with stem cells cultured with fibroblast control cells [22] . MicroRNAs (miRNAs), which are single-stranded non-coding RNA molecules, have been identified as having aberrant expression levels in cartilage and bone of humans with OA [23, 24] . This is relevant to OA, as miRNAs regulate the expression of inflammatory pathways that concern degradation of the articular cartilage ECM, such as pathways involving IL-1b or MMP-13.
[23]. miRNAs also regulate activities of substances in OA pathogenesis, such as IL-1b, TNF-a, A disintegrin and metalloproteinase with thrombospondin motifs and MMPs [25] . The study by Rainbow et al.
[22] suggests relationships exist between muscle and regulation of inflammatory pathways implicated in OA pathogenesis at a genetic level. Future research on this subject may provide some understanding of possible underlying inhibitory mechanisms of pro-inflammatory cytokines and its pathways in OA.
Pro-chondrogenic
Another example of molecular interaction relevant to OA is between muscle and cartilage [26] . Cartilage tissue is composed of chondrocytes and ECM, and the ECM is composed mostly of collagen fibres and glycosaminoglycans [27, 28] . The major collagen in cartilage is collagen II, whose structure is stabilized by collagens IX and XI [29] . Extensive cross-linking of these collagen fibres provides strength to cartilage tissue, and in OA, degradation of these collagen fibres is thought to be critical and perhaps irreversible [30] . In an in vitro study, chondrocytes cocultured with muscle cells or in a muscle cellconditioned medium were found to significantly enhance expression of collagens II and IX compared with chondrocytes co-cultured with non-muscle mesenchymal cell lines [26] . This is an attractive concept, as to date we do not have a proven modality to reverse cartilage degeneration that occurs in OA. It was speculated that cytokines and growth factors released by muscle cells, such as pro-chondrogenic insulin-like growth factor 1, potentially regulates cartilage development [26] . Future studies are required to confirm associations between muscle and its pro-chondrogenic potential in OA disease onset or progression in human studies.
Skeletal muscle composition

Skeletal muscle vs adipose tissue
Skeletal muscle mass makes up 50% of human total body weight [31, 32] . In physical deconditioning and ageing and with ensuing muscle loss or sarcopaenia, skeletal muscle is suggested to be replaced by adipose tissue [33] . Muscle quality has been recognized in the literature as determined by adipose tissue accumulation within the muscle, and alteration of muscle quality is associated with poor muscle strength [34] . Other definitions of muscle quality have been alluded to in the literature, namely muscle-specific torque per anatomical area [35] and muscle attenuation (which quantifies the proportion of inter-and intramuscular fat in muscle) [35, 36] , muscle strength relative to body weight and lean muscle mass [37] and decreased voluntary muscle activation [38, 39] . For the purposes of this review, muscle quality is defined as the proportion of muscle vs adipose tissue infiltration within muscle, with a higher ratio of muscle vs adipose tissue defined as higher quality.
Adipose tissue is considered an endocrine organ that secretes inflammatory cytokines such as IL-1b and TNF-a and adipokines such as adiponectin, resistin and to a lesser degree leptin that have been implicated in the pathogenesis of OA [4042] . Hence improving muscle quality by reducing adipose tissue infiltration potentially has metabolic and anti-inflammatory roles in OA pathogenesis.
In cross-sectional studies, fat or adipose tissue infiltration in skeletal muscle alters muscle quality [43] , reduces strength [34, 44] and has been associated with symptomatic and structural severity in knee OA [45] . In a large cross-sectional cohort, the Netherlands Epidemiology of Obesity Study, a higher ratio of total body fat mass (FM) to total body skeletal muscle mass (SMM) was associated with symptomatic and structural knee OA [46] . The association of FM:SMM ratio with symptomatic knee OA was stronger in women [1.39- [40] reported in their cross-sectional study of patients with end-stage OA undergoing total knee replacement that serum resistin was associated with the histological grade of synovial inflammation and serum adiponectin was associated with synovial tissue production of IL-1b. These findings suggest that adipokines secreted by adipose tissue play an inflammatory role in the pathogenesis of OA, and improving the quality of skeletal muscle by reducing fat tissue infiltration may be beneficial in OA pathogenesis.
Both the onset and progression of knee OA have also been associated with obesity and higher FM in studies [5052], with possible explanations being biomechanical effects of higher body weight [5355] and metabolic effects of adipose tissue [56] . The relationship between thigh muscle cross-sectional area and structural OA progression defined by MRI changes has been examined by Goldman et al.
[57] in a 48 month longitudinal study. Adjusting cross-sectional areas of the thigh for intramuscular fat, a higher cross-sectional area ratio of knee extensor:flexor muscle (E:F) was associated with an increase in patellar cartilage degeneration, but not of the tibiofemoral joint (TFJ) in persons without radiographic knee OA at baseline [57] . E:F ratios have been discussed previously in the literature in the context of anterior cruciate ligament injuries, where increased E:F strength [58] and muscle cross-sectional area [59] ratios were thought to increase the risk of anterior cruciate ligament injury. However, the majority of the literature that has examined muscle properties in knee OA have focused mainly on the quadriceps muscle. It has been shown that strengthening the hamstring muscles in addition to the quadriceps muscles improves symptoms in knee OA [60] , with the consideration that the relationship between muscle area and muscle strength may be influenced by muscle composition, as discussed above. Further research focused on separating the effects of reductions in inter-and intramuscular adipose tissue from body weight reduction on the metabolic, symptomatic and structural effects in knee OA, in addition to examining the effect of knee E:F muscle ratios, will provide further interesting insights.
Skeletal muscle fibre-type
Skeletal muscle is composed of slow-twitch fibres (type I) and fast-twitch fibres (types IIa, IIb and IIx), however, in most humans only types I, IIa and IIx are present [61, 62] . Muscle fibre type and contractile function are determined by mRNA expression of myosin heavy chain (MHC) isoforms in the various types of muscle fibres [63] . A reduction of skeletal muscle fibre numbers and an alteration of fibre type has been suggested to be linked to quadriceps weakness and pain in knee OA [64, 65] .
A cross-sectional study found that patients with early knee OA had a higher proportion of type IIb fibres in the vastus lateralis muscle and reduced eccentric but not concentric knee extensor torque when compared with healthy controls [65] . This is different from normal aging, where a decrease in type IIa and IIx fibre types and reduced muscle strength usually ensues [6668] . Fasttwitch type II fibres are thought to produce greater power and knee extensor torque than slow-twitch type I fibres [69, 70] , and despite this, lower eccentric strength was reportedly present with the predominance of type II fibres [65] . A possible explanation was that muscle activation patterns in persons with early knee OA may be different from persons with advanced knee OA [65] . This argument is consistent with the suggestion that muscle activation patterns may be associated with radiographic knee OA severity [71] . Moreover, besides early disease severity, subjects in this study were between the ages of 40 and 65 years [65] , whereas atrophy of both type I and II muscle fibres have been observed in later stages of OA and in persons of older age groups (mean age 68.5 and 71.6 years) [64, 72] .
Animal OA models have supported the finding of muscle fibre type II predominance seen in early OA, but different subtypes have been reported with increased MHC type IIx fibre expression [73] and decreased MHC type IIa fibre expression [74] . Tonge et al. [73] reported in their animal study that the onset of OA was associated with an elevation of MHC type IIx mRNA, whereas MHC types I and IIa mRNA expression were unaltered as age advanced and OA developed. The literature at present is inconclusive on skeletal muscle fibre type changes in knee OA and its association with muscle strength. Also, the association of skeletal muscle fibre type in the development or progression of OA has not been studied in humans longitudinally. Further research into this field would provide insights into the association of muscle fibre type changes in different knee OA disease severities and its application in improving muscle strength.
Skeletal muscle function
Muscle strength
Quadriceps or knee extensor muscle strength is feasibly assessed in clinical practice and has been a focus of the literature surrounding skeletal muscle function and knee OA [75, 76] . A recent systematic review reported an overall 1.65-fold (95% CI 1.23, 2.21) increased risk of developing symptomatic knee OA and a 1.58-fold (95% CI 1.12, 2.23) increased risk of developing radiographic knee OA in persons with knee extensor muscle weakness [1] . Thorstensson [77] , in a 5 year prospective study, reported that in persons with chronic knee pain, reduced functional strength (one-leg rises from sitting) had 2.6-fold (95% CI 1.1, 6.0) increased risk of developing radiographic knee OA. Knee extensor muscles are thought to serve as shock absorbers and joint stabilizers, and the loss of muscle strength results in altered joint mechanical stress that is thought to provide the rationale for increased knee OA disease onset [1, 78] .
However, whether higher strength protects against the development of knee OA is less clear. A longitudinal study from the Multicentre Osteoarthritis Study in people with high risk of developing knee OA suggests that high knee extensor strength may protect against the development of radiographic knee OA in women only [relative risk 0.52 (95% CI 0.29, 0.94)] [79] . The protective effect of higher knee extensor strength in women has been reported previously [37, 80] , but the reason why this relationship is seen in women only is unclear. It may be that baseline muscle strength in women is lower than a required absolute knee strength needed to protect the knee joint compared with baseline strength in men [79] . The study from the Multicentre Osteoarthritis Study cohort did not have sufficient statistical power to determine an association between knee extensor strength and the development of symptomatic knee OA in men or women [79] . In contrast to the above findings, a recently published longitudinal study in adolescent men with a median follow-up of 24 years reported that higher knee extensor strength at adolescence was associated with a small increased risk of knee OA by middle age (0.5% increased risk per 47 Newton-metre [Nm] higher knee extensor strength) [81] . However, the authors acknowledged that a lack of follow-up muscle strength measurements was a limitation to their study, as a loss of muscle strength later in life may have contributed to the increased risk of OA [81] . Thus, despite evidence to implicate knee muscle weakness as a risk factor for the development of knee OA [1], we do not fully know if higher baseline muscle strength is protective against the development of knee OA, and further studies are required to understand this phenomenon. Confirmation and estimation of a protective absolute knee strength, if it exists, and the influence of confounding factors requires further research.
The relationship between muscle weakness with symptomatic and structural OA progression is conflicting. A recent systematic review with meta-analysis found that individuals with lower knee extensor muscle strength have a significant increased risk of worsening of self-reported pain [1.35-fold (95% CI 1.10, 1.67)], self-reported physical function [1.38-fold (95% CI 1.00, 1.89)] and objective physical function [1.03-fold (95% CI 1.03, 1.04)] in a chairstand task, particularly in women [2] . The reason for a stronger relationship in women is again unclear and may be due to a lower muscle strength in women with knee OA than the required absolute strength to prevent symptom deterioration. However, in relation to structural progression, no evidence of an association was reported between lower knee extensor muscle strength and the risk of TFJ space narrowing [2] . It may be that lower knee extensor muscle strength, which is known to be present in persons with established knee OA [82] , provides too small a variation in strength to observe from baseline [2] .
Another possible explanation for the discordant relationship between symptomatic and structural knee OA progression is the complex mechanisms of pain. A recent meta-analysis reported that baseline knee pain is a predictive factor in radiographic knee OA progression [83] , further alluding to the complexity of the relationship between symptoms and radiographic OA progression. Although pain is the primary symptom in knee OA, the determinants of pain are not well understood. Pain is increasingly recognized to have a complex biopsychosocial model consisting of biological factors such as nociceptive pathways and central sensitization; psychological factors that include self-efficacy, pain catastrophizing and depression; and social factors such as social support and pain communication [8489] . Hence nociceptor signals from a stimulus can result in markedly different pain experiences, from no pain to severe pain, regardless of structural OA disease.
Patellofemoral pathology has been shown to be a strong source of symptoms [90] . It is possible that knee extensor muscle weakness and symptomatic knee OA progression may be related due to malalignment and abnormal loading at the patellofemoral joint (PFJ) that can occur with changes in muscle strength [91] . Additionally, knee extensor muscle weakness may have a stronger relationship with PFJ rather than the TFJ deterioration when biomechanical factors that increase compressive loads at the PFJ are considered, for example, with increased knee flexion [92] . Supporting this theory, quadriceps (knee extensor muscle) weakness has been associated with structural lateral patellofemoral OA disease in a large cross-sectional study of >2000 persons [93] , and greater quadriceps strength has been shown to protect against cartilage loss at the lateral PFJ in a longitudinal study [94] . However, a recent systematic review reported that there was inconclusive evidence of an association between lower knee extensor muscle strength with increased risk of PFJ deterioration [2] . Malalignment or knee joint laxity may adversely influence the association between knee extensor strength and structural deterioration, where greater knee extensor muscle strength is associated with structural disease progression [95, 96] , and warrants further investigation.
Muscle power is a product of force and contraction velocity [75] . It is a more critical determinant of both objective and self-reported physical function than peak isometric muscle strength in healthy older adults [97, 98] . Physical function tasks such as rising from sitting to standing and stair climbing are common difficulties faced by persons with knee OA [99, 100] . Moreover, a recent cross-sectional study reported that functional limitation, besides radiographic OA severity, is a key driver for costly total knee arthroplasty surgery eligibility [101] . Functional performance in knee OA can also be affected by knee instability and can present with symptoms such as 'buckling', which has been recognized to be multifactorial in nature (muscle strength, pain, range of movement and confidence) [102, 103] . In persons with knee OA, recent cross-sectional studies [104, 105] reported muscle power (knee extension and leg press power) being a stronger determinant of functional performance compared with knee extensor strength. Impaired biomechanical responses to simulated forward fall is present in persons with knee OA [106] and has been hypothesized to be related to a loss of muscle power [107] . However, the association between muscle power and structural knee OA progression has not been studied to date.
Collectively, studies indicate an increased risk of symptom progression but not structural progression with knee extensor muscle weakness. Further studies should include examination of structural joint deterioration in both the PFJs and TFJs and malalignment when investigating the relationship between knee extensor muscle weakness and structural OA progression. Also, muscle power measurements and functional performance measures should be included in future studies as longitudinal predictors of pain, function and structural progression.
Muscle activation
To date, no studies to our knowledge have reported an association between altered muscle activation patterns and development of knee OA. However, muscle activation patterns are reportedly altered in individuals with knee OA compared with healthy controls [39, 108, 109] and may be influenced by symptoms, although the current evidence is conflicting. Astephen Wilson et al. [110] found higher lateral hamstring and quadriceps activity during the stance phase of walking in a symptomatic OA group compared with an asymptomatic OA group with the same radiographic OA disease severity in a casecontrol study. In another recent study, greater lateral hamstring activation overall during the gait cycle and greater lateral hamstring and quadriceps activation during mid-stance were found in persons with moderate knee OA symptoms compared with asymptomatic older and younger adults [111] . Muscle activation contributes substantially to joint contact force [112] and authors have speculated that increased lateral thigh muscle activation in people with knee OA may reflect a strategy to offload the painful medial tibiofemoral compartment of the knee [108110, 113] . However, the association between measures of knee joint loading and pain in people with OA are weak and has been suggested to depend on radiographic disease severity [71] . Although some authors have speculated that OA-related pain may be a causative factor [108, 114, 115] , recent studies have reported that knee pain status does not fully explain muscle activation patterns during functional tasks in individuals with symptomatic knee OA [71, 116, 117] . Brenneman et al. [116] reported that pain did not explain the variance for total average electromyography amplitudes of muscle activation during static squat and lunge exercises in quadriceps and hamstring muscles in women with knee OA. Another study also reported that pain did not influence quadriceps, hamstring and calf muscle electromyography amplitudes in persons with mild to moderate OA during stair-climbing exercises [117] . Further research is required to better understand the underlying causes of altered muscle activation patterns in persons with knee OA.
Recent prospective data suggest an association between muscle activation and structural disease progression. Muscle co-contraction refers to simultaneous activation of agonist and antagonist muscles around a joint [118] . Hodges et al. [119] observed that the duration of medial muscle co-contraction (semimembranosus and vastus medialis) during stance was associated with annual loss of medial tibial cartilage volume. Interestingly, the lateral muscle co-contraction (biceps femoris and vastus lateralis) was found to be inversely associated with medial tibial cartilage loss in persons with knee OA [119] . Besides the duration of muscle co-contraction, the magnitude of muscle co-contraction has also been associated with structural progression [120] . Thus interventions that reduce the duration and magnitude of medial muscle cocontraction during the stance phase of the walking gait cycle may prevent medial tibial cartilage loss. These interventions can be based on gait retraining or motor skills learning principles, as previously studied in low back pain [121] and patellofemoral pain [122] , or may utilize biomechanical interventions such as knee bracing [123] . In medial knee OA, a recent pilot study reported that a 6 week intervention programme reduced the magnitude of lateral muscle co-contraction in early and mid-stance without a significant decrease of medial muscle co-contraction [124] . However, the study did not specifically target their exercise intervention to increase or decrease medial and lateral muscle co-contractions. The feasibility and effect of interventions that can reduce the duration and magnitude of medial muscle co-activation on knee OA disease progression would be useful to explore with future research.
Taken together, impaired muscle activation patterns are clearly present in persons with knee OA, but further study into the relationship between impaired muscle activation and symptomatic and structural progression is required. The literature examining the association between muscle co-contraction and knee joint load in OA is conflicting and knee joint compression has been reported as the likely variable through which muscle co-contraction affects disease progression [119] . Identifying interventions that can modify pathological muscle activation patterns will provide an opportunity to prevent disease onset in those who are at risk of knee OA and to target early intervention in those with knee OA to prevent disease progression.
Role of skeletal muscle in the management of knee OA through exercise Individuals with knee OA reportedly prefer exercise over pharmacologic treatments, with preferences driven by an unwillingness to accept the risks of drug adverse effects [125] Systematic reviews suggest that therapeutic effects of exercise for knee OA can be observed from various types of exercise [129131] . One systematic review concluded that an approach of combining exercises to increase muscle strength, flexibility and aerobic capacity is likely to be most effective in improving pain and physical function in lower limb OA [130] . However, another systematic review reported comparable improvements from a range of exercise programmes [129] . In the latter review, exercise programmes focused on a single type of exercise (aimed at improving muscle strength, aerobic capacity or lower extremity performance) were found to be more efficacious than programmes that included various exercise types within the same session [129] . Interestingly, greater pain improvement was observed with programmes focused on quadriceps strength rather than programmes focused on improving general lower limb strength [129] . Comparing quadriceps strengthening to neuromuscular exercise in persons with medial tibiofemoral knee OA with varus malalignment, a randomized controlled trial indicated that improvements in pain and self-reported physical function were comparable [132] .
An interesting recent systematic review with meta-analysis reported that muscle strength training interventions for persons with knee OA, according to the American College of Sports Medicine guidelines, provided superior gains in knee extensor muscle strength but not in pain or disability [133] . A minimum of 30% and 40% increase in knee extensor muscle strength is necessary for a likely beneficial effect on pain and disability, respectively [133] . Achieving a 3040% increase in knee extensor muscle strength in persons with knee OA could be challenging, considering coexisting pain and disability, but gradual increments, combined with power training, could have further therapeutic benefits.
The types of strengthening interventions recommended include concentric (shortening) and eccentric (lengthening) muscle strengthening that includes multiple joint groups, with emphasis on training opposing muscle groups (antagonist muscles), such as the quadriceps and hamstrings and abdominals and lumbar extensor muscles [134, 135] . To improve strength, two to four sets of resistance exercise per muscle group has been recommended to improve strength, performed two to three times a week, with a rest period of 4872 h between sessions [134, 136] . Muscle hypertrophy and increased strength are seen from using 6080% of one-repetition maximum (1-RM) [134, 136] , where 1-RM is the maximum weight that can be lifted once with the correct technique [137, 138] . In an older or very deconditioned person, a lower resistance of 4050% 1-RM may be used at the start of an exercise programme combined with exercises that focus on the development of power [134] . A meta-analysis reported that resistance training at 60% 1-RM produced the largest effect sizes for strength gains in untrained individuals, whereas training at 80% 1-RM produced the largest effect sizes for improvement in strength in trained individuals [135, 139] .
There is increasing interest in the literature with respect to the intensity of exercise for people with knee OA, with an ongoing clinical trial evaluating high-intensity muscle strength training in persons with knee OA [140] . A recent 12 week moderate-intensity muscle strength training programme was shown to have minimal skeletal muscle cellular and molecular adaptations despite improvements in knee extensor muscle torque and quadriceps muscle cross-sectional area [141] . Single muscle fibre hypertrophy was modest or absent, and mitochondrial content within the muscle cell increased in men, but not in women, in response to moderate-intensity strength training [141] . This is an interesting finding and has clinical implications, as it may be that higher intensity strength training is required to achieve cellular and molecular adaptations in the skeletal muscle in knee OA. Further research is required to determine whether cellular and molecular adaptations underpin improvements seen in OA symptoms.
The literature on strength training regimes in the past has been heterogeneous in terms of dosage and duration [133] , with details of protocols sometimes not fully reported, which provides challenges for replication of future studies. Future studies should aim to provide details on strengthening exercise regimes, enabling exploration of ideal exercise intensity thresholds for improvement and safety [140, 142, 143] . Further research could focus on exercise regimes with a combination of progressive muscle strength training and power training for persons with knee OA.
Although exercise is an effective treatment for individuals with knee OA, effect sizes are modest [131] and there is room to improve outcomes. Tailoring exercise programmes to participant characteristics as recommended by clinical guidelines [5] may enhance outcomes. Exploratory analyses from a clinical trial suggest that varus thrust and obesity may influence the pain-relieving effects of neuromuscular exercise and quadriceps strengthening exercises [144] . These observations require validation but may be particularly relevant given that many people with knee OA are obese [145, 146] . An understanding of mechanisms underpinning improvements in pain and physical function will enable health professionals to better tailor exercise programmes towards mechanistic factors and thereby optimize outcomes. Despite evidence since 2002 that exercise improves knee OA symptoms [130] , little is understood about the underlying mechanisms underpinning symptomatic benefits of exercise in individuals with knee OA. It is hypothesized that exercise can address several impairments of knee OA, including proprioception, inflammation, depression and self-efficacy [147149] . However, given the epidemiological evidence implicating the role of muscle strength in knee OA [1] , it is reasonable to hypothesize that alterations in skeletal muscle in response to exercise is likely to be a key determinant in symptom improvement.
Conclusion
Skeletal muscle structure and function have been implicated in both knee OA disease development and progression. Research into how the function of skeletal muscle, its quality and composition and its biochemical and molecular interactions work in knee OA pathogenesis may help our understanding of this topic. Understanding the role of skeletal muscle in knee OA disease development and progression will facilitate optimization of treatments, such as exercise therapy programmes. Although the benefit of improved muscle function, and especially muscle strength, in exercise programmes in knee OA is increasingly recognized, the mechanisms behind the positive effects are poorly understood. Specific exercise recommendations for individuals with knee OA are challenging due to the heterogeneity of OA disease and its exercise interventions. Further research should also focus on the type of exercise, duration and intensity of specific muscle-focused exercise protocols while studying properties of skeletal muscle. 
